Jellagen company
![](/files/companies/Jellagen.png)
Collagen-based innovation that addresses complex tissue engineering and regenerative medical needs, helping to shape next-generation medical treatments alongside current and future scientific research.
Headquarters:
Pembroke Dock, Pembrokeshire, United Kingdom
Number Of Exists:
Series B
Total Funding:
£5.7M
Founded Date:
7-5
Employee Number:
1-10
Investment Stage:
N/A
Last Funding Type:
Series B
Investor Type:
Company
Investors Number:
5
Technology:
Regenerative Medicine
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Industry:
Regenerative Medicine